🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Vandetanib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-03
Trial ID
NCT00734890
Treatments Being Tested
The goal of this prospective observational cohort study is to assess the op...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06684899
This phase I trial studies the side effects and best dose of expanded natur...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-03-17
Trial ID
NCT02271711
Treatments Being Tested
Post endoscopic pancreatitis (PEP) has different initial immunologic respon...
Status
Unknown
Location
Clinical Hospital Centre
Start Date
2018-01-31
Trial ID
NCT02602574
Treatments Being Tested
Phase II trial to study the effectiveness of combining interleukin-12 and i...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
2001-10
Trial ID
NCT00026143
Treatments Being Tested
This study tests the safety and preliminary anti-tumor activity of an inves...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-02
Trial ID
NCT07486089
Treatments Being Tested
The primary objective of this study is to establish differences in suscepti...
Status
Completed
Location
Hospital Ramon y Cajal
Start Date
2020-08-01
Trial ID
NCT04402827
Treatments Being Tested
This phase II clinical trial studies how well personalized natural killer (...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-05-19
Trial ID
NCT02727803
This example planning study proposes a phase 1/2 evaluation of an allogenei...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07551362
Treatments Being Tested
This phase II trial studies how well talimogene laherparepvec and nivolumab...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2017-09-27
Trial ID
NCT02978625